Source: FinanzNachrichten

TISSIUM: TISSIUM Announces Clinical Results of COAPTIUM CONNECT System for Atraumatic Sutureless Nerve Repair

Paris, France, Cambridge, USA, April 2nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data w...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Christophe Bancel's photo - Co-Founder & CEO of TISSIUM

Co-Founder & CEO

Christophe Bancel

CEO Approval Rating

85/100

Read more